Tuesday, 02 January 2024 12:17 GMT

United States Virology, Bacteriology, Parasitology And Mycology Market Forecasts And Supplier Shares: Supplier Shares And Future Forecasts Revealed For Major Infectious Disease Tests


(MENAFN- GlobeNewsWire - Nasdaq) Discover the latest supplier shares and projections for major infectious disease tests through 2028. This comprehensive database includes innovations in AIDS/HIV, Hepatitis, Malaria, and more, detailing companies leading advancements in infectious disease diagnostics.

Dublin, July 02, 2025 (GLOBE NEWSWIRE) -- The "2025 U.S. Virology, Bacteriology, Parasitology and Mycology Market Forecasts and Supplier Shares: Shares, Volume and Sales Segment Forecasts for 100 Respiratory, STD, Gastrointestinal and Other Microbiology Tests" has been added to ResearchAndMarkets.com's offering.

The latest database offers an in-depth analysis of the infectious disease testing landscape, highlighting the 2023 supplier shares and projecting the volume and sales forecasts from 2023 to 2028.

It encompasses a detailed overview of 100 major infectious disease tests, providing insights into the companies involved in the development and marketing of innovative technologies and products tailored to specific tests.

This extensive collection covers a broad array of infectious diseases, providing vital data and forecasts for tests related to:

  • AIDS/HIV
  • Adenovirus
  • Aeromonads
  • Bartonella
  • Blastocystis Hominis
  • Campylobacter
  • Candida
  • Carbapenemase
  • Chancroid
  • Chlamydia
  • Clostridium
  • Coronavirus
  • Coxsackievirus
  • Cryptosporidium
  • Cyclospora
  • CMV
  • E. Coli
  • Echovirus
  • Encephalitis
  • Enterovirus
  • EBV
  • Giardia
  • Gonorrhea
  • Granuloma Inguinale
  • Hantavirus
  • H. Pylori
  • Hepatitis
  • Herpes
  • Influenza
  • Legionella
  • Lyme Disease
  • Lymphogranuloma
  • Malaria
  • Measles
  • Meningitis
  • Microsporidium
  • Mononucleosis
  • Mumps
  • Mycoplasma
  • Norovirus
  • HPV
  • Parvovirus
  • Pneumonia
  • Polyomaviruses
  • Pseudomonas
  • Rabies
  • RSV
  • Rhinovirus
  • Rotavirus
  • Rubella
  • Salmonella
  • Septicemia
  • Shigella
  • Staphylococci
  • Streptococci
  • Syphilis
  • Toxoplasmosis
  • Trichomonas
  • TB
  • Vibrio
  • West Nile
  • Yersinia

The database serves as a critical resource for stakeholders seeking to understand the current market dynamics and future trends shaping the infectious disease testing sector. By analyzing the competitive landscape and pinpointing strategic areas for growth, businesses can make informed decisions on investments and initiatives to gain a competitive edge.

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: Laura Wood,Senior Press Manager ... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN02072025004107003653ID1109750757


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search